The current financial score of Natural Alternatives International Inc is 6.82. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 35.48M, representing a year-over-year increase of 23.35%, while its net profit experienced a year-over-year increase of 97.21%.
The current valuation score of Natural Alternatives International Inc is 9.15. Its current P/E ratio is -0.78, which is -7032.70% below the recent high of 54.02 and -1458.43% above the recent low of -12.14.
No earnings forecast score is currently available for Natural Alternatives International Inc. The Pharmaceuticals industry's average is 7.83.
The current price momentum score of Natural Alternatives International Inc is 4.41. Currently, the stock price is trading between the resistance level at 2.20 and the support level at 1.69, making it suitable for range-bound swing trading.
The current institutional shareholding score of Natural Alternatives International Inc is 3.00. The latest institutional shareholding proportion is 40.11%, representing a quarter-over-quarter increase of 19.43%. The largest institutional shareholder is James Simons, holding a total of 277.46K shares, representing 0.00% of shares outstanding, with 42.36% decrease in holdings.
The current risk assessment score of Natural Alternatives International Inc is 2.78. The company's beta value is 0.38. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.